first "biologic therapy" for allergy-related asthma, called Xolair (ZO-lair)
July 2003
The FDA just approved the first "biologic therapy" for allergy-related asthma, called Xolair (ZO-lair).
Xolair (omalizumab) is an important new option...but only for a select group of asthma patients.
It's only for patients with moderate to severe asthma triggered by an allergic reaction...only when inhaled steroids aren't enough...and only in patients 12 and older.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote